Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 family 4 subfamily F member 33, pseudogene (CYP4F33P) is a human pseudogene belonging to the cytochrome P450 (CYP) superfamily[1]. Pseudogenes such as CYP4F33P are DNA segments highly similar to protein-coding genes but rendered nonfunctional due to mutations or truncations; they do not produce functional proteins[1][3]. The CYP4F subfamily is part of a larger group of enzymes (CYPs) involved in the metabolism of endogenous and xenobiotic compounds, but CYP4F33P itself does not have a protein-coding function or therapeutic relevance[1][2][4]. Thus, it is not considered a therapeutic target, lacks enzyme or receptor activity, and has no known biological, disease, or pharmacological role.
Not applicable for a pseudogene
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 family 4 subfamily F member 33, pseudogene (CYP4F33P).